Malecare

About Malecare

Malecare is the world's leading men's cancer support and advocacy nonprofit organization.

On The Horizon- Coming Soon – Radium-223 (Alpharadin) A Bone Targeted Treatment for Advanced Prostate Cancer that Extends Life

At the recent European Multidisciplinary Cancer Congress in Stockholm, Dr Chris Parker from The Royal Marsden Hospital presented results of the phase 3 ALSYMPCA trial that showed both delayed time to first skeletal-related event (SRE) AND an overall survival (OS) benefit for those men with advanced prostate cancer taking radium-223 (Alpharadin). The real significance of [...]

By |2011-10-04T15:33:19-04:00October 4th, 2011|abiraterone acetate, Advanced Prostate Cancer, Alpharadin (radium-223), bisphosphonates, Cabazitaxel, Chemo Therapy Failure, Clinical Trials, Clinical Trials, denosumab - Xgeva, Drugs & Treatments, On The Horizon, Uncategorized, Zometa|1 Comment
Read More

HOUSE, SENATE AT ODDS OVER NIH, NCI FUNDING

OK, I give up. I clearly don’t understand American politics! A new House proposal puts research funding at center of broader FY2012 budget debate, but not the way I would have predicted. In a surprise move the Republican House leaders released a draft proposal that would increase fiscal year 2012 funding for the National Institutes [...]

By |2017-10-19T10:52:03-04:00October 2nd, 2011|Advanced Prostate Cancer, Advocacy, Financial, General Information, Politics of Cancer, Uncategorized|1 Comment
Read More

Three Types of Aggressive Prostate Cancer Have Their Genomes Mapped

Finally, advanced prostate cancer makes it into the genomeic world of cancer. Researchers at the Fred Hutchinson Cancer Research Center and the University of Washington in Seattle published in this week's online edition of the Proceedings of the National Academy of Sciences an announcement that they have mapped the genomes of three different types of [...]

By |2017-10-19T10:52:03-04:00September 27th, 2011|Advanced Prostate Cancer, genetics, Genomics, Research, Uncategorized, Understanding APC|1 Comment
Read More

Ask the Obama Administration to Light the White House Blue – We Need 5,000 Signatures

Malecare has just started a new petition asking that the Obama administration to: Light The White House Blue on Men's Health Night, November 21, in order to raise Prostate and Testicular cancer awareness. If we are able to get 5,000 signatures by October 22, 2011 we will get a response back from the Obama Administration. [...]

By |2021-02-17T11:03:30-05:00September 22nd, 2011|Advanced Prostate Cancer, Advocacy, Politics of Cancer, Uncategorized|0 Comments
Read More

FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Men with Prostate Cancer Undergoing ADT

Amgen announced that the U.S. Food and Drug Administration (FDA) has approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in men receiving androgen deprivation therapy (ADT) for non-metastatic prostate cancer. Men receiving ADT are at high risk for developing fractures, including vertebral fractures, which can cause paralysis. "Bone loss [...]

By |2011-09-19T10:59:59-04:00September 19th, 2011|Advanced Prostate Cancer, Bone Mineral Density, Drugs & Treatments, FDA, General Information, Hormone Therapy, Prolia (denosumab), Uncategorized, Understanding APC|3 Comments
Read More

Genetics & Calcium Might Increase Risk for Prostate Cancer In the African-American Men

A study by at Wake Forest Baptist Medical Center in Winston-Salem N.C., Keck School of Medicine at the University of Southern California (USC) and the Cancer Prevention Institute of California suggests that a high intake of calcium causes prostate cancer among African-American men who are genetically good absorbers of the mineral. According to Gary G. [...]

By |2017-10-19T10:52:04-04:00September 16th, 2011|Advanced Prostate Cancer, Diet, Diet and Supplements, General Information, genetics, Genomics, Research, Uncategorized, Understanding APC|0 Comments
Read More
Go to Top